ArticleJournal of clinical medicine2020
Short-Period Temporal Dispersion Repolarization Markers Predict 30-Days Mortality in Decompensated Heart Failure.
Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 12 citations in OpenAlex.
- Non-Invasive Wearable Technology to Predict Heart Failure Decompensation.Journal of clinical medicine · 2025Review
- Sex Differences in Repolarization Markers: Telemonitoring for Chronic Heart Failure Patients.Journal of clinical medicine · 2023Article
- Chronic Heart Failure Management: Monitoring Patients and Intercepting Exacerbations.Reviews in cardiovascular medicine · 2023Review
- Electrocardiographic and other Noninvasive Hemodynamic Markers in Decompensated CHF Patients.Journal of cardiovascular development and disease · 2023Article
- A Longer TJournal of clinical medicine · 2023Review
- QT and Tpeak-Tend interval variability: Predictive electrical markers of hospital stay length and mortality in acute decompensated heart failure. Preliminary data.Clinical cardiology · 2022Article
- Noninvasive Hemodynamic Monitoring in Advanced Heart Failure Patients: New Approach for Target Treatments.Biomedicines · 2022Article
- Glucose dysregulation and repolarization variability markers are short-term mortality predictors in decompensated heart failure.Cardiovascular endocrinology & metabolism · 2022Article
- Ventricular repolarization indicators in risk stratification of decompensated heart failure patients with ventricular systolic dysfunction.Caspian journal of internal medicine · 2022Article
- Periodic repolarization dynamics as predictor of risk for sudden cardiac death in chronic heart failure patients.Scientific reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesElectrocardiographic (ECG) markers of the temporal dispersion of the myocardial repolarization phase have been shown able to identify chronic heart failure (CHF) patients at high mortality risk. The present prospective single-center study sought to investigate in a well-characterized cohort of decompensated heart failure (HF) patients the ability of short-term myocardial temporal dispersion ECG variables in predicting the 30-day mortality, as well as their relationship with N-terminal Pro Brain Natriuretic Peptide (NT-proBNP) plasmatic values.
methodOne hundred and thirteen subjects (male: 59, 67.8%) with decompensated CHF underwent 5 min of ECG recording, via a mobile phone. We obtained QT end (QTe), QT peak (QTp) and T peak to T end (Te) and calculated the mean, standard deviation (SD), and normalized index (VN).
resultsDeath occurred for 27 subjects (24%) within 30 days after admission. Most of the repolarization indexes (QTe mean (
conclusionBoth mean Te and Te
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.